Join
Live feed
·
SECFilingvia Quantisnow
NGM Biopharmaceuticals Inc. logo

NGM Biopharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Temporary Suspension of Trading Under Registrant’s Employee Benefit Plans, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
NGM· NGM Biopharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NGM (NGM Biopharmaceuticals Inc.) and more on Quantisnow.

NGM Biopharmaceuticals Inc. filed SEC Form 8-K: Leadership Update, Temporary Suspension of Trading Under Registrant’s Employee Benefit Plans, Financial Statements and Exhibits | Quantisnow